-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QY8m1jGZ5r3YExY+F1kdxCLELZ+tlrZr85NsSaujYwY4V9G93pEz2tHMBPsRq6St iqBU09R2g0lcFNhhH+TWuQ== 0001144204-10-059671.txt : 20101112 0001144204-10-059671.hdr.sgml : 20101111 20101112143657 ACCESSION NUMBER: 0001144204-10-059671 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100930 FILED AS OF DATE: 20101112 DATE AS OF CHANGE: 20101112 EFFECTIVENESS DATE: 20101112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INERGETICS INC CENTRAL INDEX KEY: 0000072170 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221558317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-03338 FILM NUMBER: 101185635 BUSINESS ADDRESS: STREET 1: 665 MARTINSVILLE ROAD, SUITE 219 CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-604-2500 MAIL ADDRESS: STREET 1: 665 MARTINSVILLE ROAD, SUITE 219 CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: MILLENNIUM BIOTECHNOLOGIES GROUP INC DATE OF NAME CHANGE: 20020515 FORMER COMPANY: FORMER CONFORMED NAME: REGENT GROUP INC /DE DATE OF NAME CHANGE: 19980425 FORMER COMPANY: FORMER CONFORMED NAME: INTERNATIONAL MADISON HOLDINGS CORP DATE OF NAME CHANGE: 19971217 NT 10-Q 1 v202124_nt10q.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

SEC FILE NUMBER
0-3338
CUSIP NUMBER
60038H 10 2
                              
 
 
(Check One):  o Form 10-K   o Form 20-F  o Form 11-K   x Form 10-Q    oForm 10-D   o Form N-SAR   o Form N-CSR

          For Period Ended:        9/30/10             
          (   ) Transition Report on Form 10-K
          (   ) Transition Report on Form 20-F
          (   ) Transition Report on Form 11-K
          (   ) Transition Report on Form 10-Q
          (   ) Transition Report on Form N-SAR
          For the Transition Period Ended:_____________________________________
 
 
 
 Read Instructions (on back page) Before Preparing Form. Please Print or Type.

      NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION
                 HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
 
 
     If the notification relates to a portion of the filing checked above,
            identify the Item(s) to which the notification relates:

 
PART I -- REGISTRANT INFORMATION
 
 
Full Name of Registrants:

Inergetics, Inc.
Former Name if Applicable

Millennium Biotechnologies Group, Inc.
Address of Principal Executive Offices (Street and Number)

205 Robin Road, Suite 222
City, State and Zip Code

Paramus, NJ 07652
 
 
PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed (Check box if appropriate)

(a) 
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
x
(b) 
The subject quarterly report on Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date; and 
 
(c) 
The accountant's statement or other exhibit required byRule 12(b)-25(c) has been attached if applicable.


PART III - -- NARRATIVE

State below in reasonable detail the  reasons  why the Form 10-Q could not be filed within the prescribed time period. (Attach Extra Sheets If Needed)


“The financial statements and Managements Discussion are not completed.”
 
 
PART IV - -- OTHER INFORMATION
 
(1)
Name and telephone number of person to contact in regard to this  notification:

 
 
Michael C. James 
  (908)   604-2500 
 
Name 
 Area Code Telephone Number
 
 
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
 
  x Yes o No
       
 
 
    
 
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
 
  o Yes x No
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
          
 
Inergetics, Inc. (f/k/a Millennium Biotechnologies Group, Inc.)
(Name of Registrant as Specified in Charter)
 
has caused this  notification  to be signed on their behalf by the undersigned hereunto duly authorized.
                                         

 Date
 November 12, 2010
  
By:
 /s/ Michael C. James  
        Michael C. James  

Instruction: The form may be signed by an executive officer of the registrant or by any other duly  authorized  representative.  The name and title of the person signing the form  shall  be typed or  printed  beneath  the  signature.  If the statement is signed on behalf of the registrant by an authorized  representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

 
----------------------------------------------------------------------------ATTENTION-----------------------------------------------------------------------------
INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
VIOLATIONS (SEE 18 U.S.C. 1001).
 

 
 -----END PRIVACY-ENHANCED MESSAGE-----